Additionally, we obtained the mutation landscape of these six DE-TF signature genes coupled with five frequently mutated genes in CRC, namely BRAF, EGFR, PIK3CA, KRAS, and NRAS (Figure 4E). This evidence concerns the gene KRAS and colorectal carcinoma.